Abeda Jamadar

The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease

J. Calvet, D. Wallace, T. Fields, 2021, Cell Death & Disease.

New Difluoro Knoevenagel Condensates of Curcumin, Their Schiff Bases and Copper Complexes as Proteasome Inhibitors and Apoptosis Inducers in Cancer Cells

Sanjeev Banerjee, F. Sarkar, Q. Dou, 2009, Pharmaceutical Research.

Glycogen synthase kinase‐3β inhibits tubular regeneration in acute kidney injury by a FoxM1‐dependent mechanism

J. Woodgett, T. Fields, N. Dwivedi, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.

T. Fields, N. Dwivedi, A. Jamadar, 2022, Kidney international.

Glycogen Synthase Kinase-3 Signaling in Acute Kidney Injury

A. Jamadar, Reena Rao, Abeda Jamadar, 2020, Nephron.

Circadian clock disruption and growth of kidney cysts in autosomal dominant polycystic kidney disease

M. Gumz, Abeda Jamadar, N. Pabla, 2024, bioRxiv.

Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer

Aamir Ahmad, Sanjeev Banerjee, F. Sarkar, 2012, Pharmaceutical Research.

Synthesis, characterisation and antitubercular activities of a series of pyruvate-containing aroylhydrazones and their Cu-complexes.

A. Duhme-Klair, P. Dandawate, S. Padhye, 2012, Dalton transactions.

Circadian clock disruption and growth of kidney cysts in autosomal dominant polycystic kidney disease

M. Gumz, Abeda Jamadar, N. Pabla, 2024, bioRxiv.

Targeting the Vasopressin Type 2 Receptor for Renal Cell Carcinoma Therapy

R. Weiss, J. Calvet, N. Dwivedi, 2019, Oncogene.